Jun 18, 2013 | streetinsider.com
Park City, UT (PRWEB) June 18, 2013 NuView Life Sciences (NLS), a privately held company developing next generation imaging and in vitro diagnostic (IVD) biomarkers, today announced the results from a translational research...
Read more...
NuView Prostate Bladder VPAC1 NLS-VPAC1 Cancer urine NuView’s TP4303 n presentation NLS detect cell
Jun 17, 2013 | bullfax.com
By The Burrill Report: By Vinay Singh Johnson & Johnson (JNJ) released interim data from a late-stage study that showed its prostate cancer drug, Zytiga, improved survival of men with less advanced forms of the disease. The...
Read more...
Zytiga Johnson&Johnson drug developer .Zytiga JNJ Equities:These ByEmerging Geschek prostate cancer Invokana blockbuster $961 million Invega FDA
14 hrs ago | medgadget.com
EDAP TMS of Vaulx-en-Velin, France received CE Mark approval for its Focal•One robotic High-Intensity Focused Ultrasound (HIFU) system for non-invasive treatment of prostate cancer. The system overlays and fuses 3D MR imaging...
Read more...
Focal•One High-Intensity ultrasound prostate robotic cancer EDAP
15 hrs ago | healthmedicinet.com
—Among men with very-low-risk prostate cancer (PCa) who meet criteria for active surveillance but undergo radical prostatectomy, African-American race is associated with poorer outcomes, with higher rates of disease upgrading...
Read more...
PCa oncologic very-low-risk low-risk prostatectomy racial African-American outcome pathologic
22 hrs ago | getholistichealth.com
Image Credits Immunotherapy, which is generally used for cancer treatment in adults, can be modified to accommodate child care as well. According to recent research, an estimated 11,630 cases of pediatric cancer will be...
Read more...
Tsvetan Petrov cancer immunotherapy therapy child lymphocyte pediatric patient prostate cell vaccine
Jun 17, 2013 | huffingtonpost.com
Scientists have identified the mechanism by which cancer is able to spread throughout the body, after discovering a cell movement process called "chase and run." The findings, published in the journal Nature Cell Biology ,...
Read more...
All similar articles: 82 »
cancer prostate em href cell placode PSA metastasis researcher spread study-psa-testing-cuts-worst-prostate-cancers 2003392.html surgery-rarely-best-prostate-cancer-study-suggests all-routine-psa-tests-for-prostate-cancer-should-end-task-force-says .UJrg9m 16805902 153234671 night-shift-prostate-cancer-health www.webmd.com www.huffingtonpost.com prostate-cancer http
13 hrs ago | medscape.com
Dr. Vickers talks with Dr. Carlsson about studies that provide clear insights into whom to screen, biopsy, and treat for prostate cancer, and where outcomes are the best for patients. Medscape Urology (Source: Medscape Today...
Read more...
All similar articles: 93 »
Medscape clinical drug&disease medical CME Smartphone Reference CE Complete
Jun 18, 2013 | advanceweb.com
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) applauds the Centers for Medicare and Medicaid Services (CMS) on the ruling issued on coverage for positron emission tomography (PET) procedures. Focusing on the...
Read more...
SNMMI NOPR CMS PET scan coverage FACNM NaF 18F-FDG Dillehay
Jun 18, 2013 | birminghamstar.com
diabetes self-management, as well as the role of prostastic acid phosphatase (PAP) in Prostate Cancer (PCa) bone metastases; identify new molecules that can stimulate the thyroid gland; reveal the prevalence of primary...
Read more...
Autoimmunity thyroid metastasis diabetes bone Prostate prostastic aldosteronism PCa
15 hrs ago | proactiveinvestors.com
One of the biotech laggards of the year, Medivation ( NASDAQ: MDVN ) saw a very high volume selloff ( -6.78% ▼ $47.41/share ) yesterday after rival Johnson & Johnson ( NYSE: JNJ ) announced the acquisition of Aragon...
Read more...
Xtandi Medivation pre-chemo mCRPC Zytiga ARN J&J 509 PREVAIL acquisition MDVN
Jun 17, 2013 | redliontrader.com
Amgen ( AMGN ) recently received approval from the US Food and Drug Administration (FDA) for an additional indication for Xgeva (denosumab). The FDA approved Xgeva for the treatment of giant cell tumor of bone (GCTB) that...
Read more...
Xgeva Amgen Prolia bone fracture metastasis osteoporosis GCTB FDA label prostate cancer ANIK approval
14 hrs ago | cancernetwork.com
This article will review these intersections of exercise and oncology, discuss the known mechanisms by which exercise exerts its salutary effects, and touch upon the future directions of exercise research in the oncology...
Read more...
Dawn Lemanne exercise cancer activity treatment Survivorship physical study chemotherapy decrease breast prevention patient miles per hour
Jun 17, 2013 | onclive.com
Published Online: Monday, June 17, 2013 The quest to deliver optimal radiation therapy for patients with prostate cancer has led to a variety of advances in technologies and techniques, yet key questions remain unanswered....
Read more...
proton therapy radiation Sandler Prostate IMRT Cancer optimal beam CaPSURE method study
Jun 17, 2013 | retractionwatch.wordpress.com
A cancer researcher whose work was the subject of a lawsuit has retracted his fifth paper, this one from 2004. Robert Getzenberg, formerly of the University of Pittsburgh and Johns Hopkins, has had two papers on prostate cancer...
Read more...
Getzenberg Hopkins Pitt BLCA-4 researcher fifth retract cancer cDNA paper Tennesseee-based encode
Jun 17, 2013 | modernmedicine.com
A relatively new imaging system demonstrates a higher capacity for mapping recurrent prostate cancer than integrated positron emission tomography and computed tomography, researchers recently reported at the Society of Nuclear...
Read more...
PET MR prostate recurrent imaging tomography metastasis cancer C-11 choline positron Eiber map patient CT CT.
Jun 17, 2013 | networkusall.com
http://www.elizabethwarren.com/crushed Our kids owe a trillion dollars in student loan debt. That's more than all the credit card debt in America combined. O... Video Rating: 4 / 5 Glendale, CA (PRWEB) August 23, 2012 For...
Read more...
Audio-Digest Continuing Chickenpox Surgery Education Psychopharmacology Medical Demand Mesh ADHD Alzheimer Of Medicine improve management
Jun 18, 2013 | newslocker.com
Discovery Of Source Of Tumor Growth In Aggressive Prostate Cancer Researchers have discovered a molecular switch that explains, at least in part, how some fast-growing prostate cancers become resistant to hormone treatment, a...
Read more...
prostate discovery cancer bone Excessive Affected Consumption Salt high-salt By Adolescents Palsy Cerebral Endocrine Vibration Of Tumor Aggressive
Jun 18, 2013 | oneradionetwork.com
By Dr. Alison Adams, Contributor Dr Alison Adams, Dentist, Naturopath and Author (The Natural Recovery Plan) One Radio Network Cancer: Early Detection Angelina Jolie: Prophylaxis gone mad? Angelina Jolie has recently chosen to...
Read more...
cancer screening prostate Jolie Prophylaxis mammography breast disease Angelina doctor surgery
Jun 18, 2013 | philly.com
BALINT POMECZI / Bloomberg News Posted: Tuesday, June 18, 2013, 3:01 AM Campbell buys Danish cookie-maker Campbell Soup Co. said it reached an agreement to buy the maker of the popular Royal Dansk Danish butter cookies sold in...
Read more...
MicroDose Kelsen Aragon Trevose J&J Brubaker Campbell prostate Teva Harold POMECZI Huntingdon cancer inhaler cell-transplant Cancer-treatment cookie-maker BALINT Nørre Snede Bloomberg
20 hrs ago | commonwealmagazine.org
It took me about three weeks to get from my strangely embarrassed general practitioner's admission that I have gotten some bad numbers on my prostate cancer blood test to the Big Day when I got the definitive biopsy results....
Read more...
cancer spirituality prostate biopsy perspective surgery book spiritual urologist frailty McHugh
Jun 17, 2013 | yahoo.com
Johnson & Johnson agrees to acquire Aragon Pharmaceuticals Johnson & Johnson announced a definitive agreement to acquire Aragon Pharmaceuticals, a privately-held, pharmaceutical discovery and development company focused on...
Read more...
J&J Medivation MemoryShape STELARA prostate Johnson&Johnson Aragon cancer psoriatic implant Janssen Mentor arthritis androgen
18 hrs ago | ru.wordpress.com
Here is our comprehensive IHC tissue control list. It is also posted as one file under the histology section. There are 16 pages of our version, but I will try to condense it here for you. These controls are all human tissues....
Read more...
Histologistics Tonsil BM Skin carcinoma Spleen Placenta Pancreas colon Cytokeratin
Jun 17, 2013 | iamcure.org
Johnson & Johnson (JNJ), the world’s biggest maker of health-care products, agreed to buy Aragon Pharmaceuticals Inc. and its experimental prostate cancer drug in a deal worth as much as $ 1 billion. Aragon will receive an...
Read more...
All similar articles: 274 »
Aragon J&J cancer prostate pharmaceutical Bloomberg ARN-509 $ candidate
6 hrs ago | crownheights.ch
Watching and routinely examining men with early, slow-growing prostate cancer is more effective and cheaper than sending them to surgery or radiation right away, according to a new study. The findings are based on a model of...
Read more...
All similar articles: 65 »
prostate watchful cancer Hayes treatment waiting surveillance wilt low-risk observation model active
19 hrs ago | medindia.net
A new study to be presented at The Endocrine Society's 95th Annual Meeting in San Francisco reveals that aggressive and drug resistant forms of prostate cancer can be treated with a new drug known as pyrvinium pamoate. "Our...
Read more...
All similar articles: 66 »
prostate androgen cancer pyrvinium AR aggressive resistant drug pamoate prostate-cancer receptor inhibit hormone
Jun 17, 2013 | cancerlive.net
BPA is a synthetic estrogen that is used to add flexibility to many common products, including food cans and containers, compact discs, eyeglasses, and even baby bottles. It is universally prevalent, and tests indicate that...
Read more...
All similar articles: 143 »
BPA prostate tissue cell stem human exposure cancer risk estrogen chemical endocrine-disrupting mouse
Jun 17, 2013 | medindia.net
Several new studies will be presented by researchers from the Icahn School of Medicine at Mount Sinai at ENDO 2013, The Endocrine Society's Annual Meeting (and) Expo (ENDO) from June 15-18 in San Francisco. Mount Sinai...
Read more...
thyroid PCa Sinai Mount cell Glucose Diabetics ENDO patient Meters ER Levine bone molecule PAP metastasis Dr. Their Monitor study
Jun 18, 2013 | about-health.nu
Email Print Dear Dr. Roach: In 2008, I was treated for prostate cancer with radiation. A couple of months later, I started passing blood during bowel movements. I went to a gastroenterologist, who found that my colon was...
Read more...
colon radiation Plavix stents trigeminal bleeding neuralgia Canasa burn tumor headache Roach pain suppository clopidogrel hyperbaric cardiac gastroenterologist y9uOutBV0E1YV6gtuyDrtIOK0 7039060-95 to-your-good-health-colon-burned-by-radiation brain
20 hrs ago | fortmilltimes.com
DUBLIN -- Research and Markets has announced the addition of the "Triple Analysis: Melanoma, Prostate Cancer and Cancer Vaccines" report to their offering. This triple analysis focuses on cancer drug development strategies in...
Read more...
melanoma cancer drug prostate triple vaccine Ceased strategy Marketed analysis Vaccines research development target identified defined extensively jjnvm7 assess
4 hrs ago | therebel.org
Prostate cancer continues to be one of the most prominent forms of the disease, accounting for more than 235,000 diagnoses each year in the U.S. alone, with nearly 30,000 deaths. As with many forms of cancer, prostate cancer is...
Read more...
prostate pomegranate cancer broccoli tea green fight polyphenol-rich
